Menu Back toSession-0505-Post-Marketing-Safety-Surveillance
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
The 7th DIA China Annual Meeting
Session 0505 Post Marketing Safety Surveillance
- Associate Director, Safety Surveillance & Risk Management
- Pfizer, China
Evidence Triggered and Evidence Based - Thinking of Postmarking Drug Safety Issues (CN&EN)
- Huashan Hospital, Fudan University, China
Signal Detection during Post-marketing Surveillance(CN&EN)
- Tigermed, China